SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-026582
Filing Date
2021-05-11
Accepted
2021-05-11 16:30:34
Documents
3
Period of Report
2021-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20210511.htm 8-K 32201
2 EX-99.1 abio-ex991_6.htm EX-99.1 88918
3 GRAPHIC g5lggkl0umxl000001.jpg GRAPHIC 20861
  Complete submission text file 0001564590-21-026582.txt   151331
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 21911733
SIC: 2835 In Vitro & In Vivo Diagnostic Substances